Accelerated laser resurfacing wound healing using a triad of topical antioxidants

Dermatologic Surgery

Volumn 24, Issue 6, 1998, Pages 661-664

  McDaniel, David H ^a,b   Ash, Keith ^c   Lord, Jeff ^c   Newman, John ^c   Zukowski, Mark ^c  

^a Laser Skin & Vein Center of Virginia   (United States)

^b EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^c NAVAL MEDICAL CENTER PORTSMOUTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ELTA; PETROLATUM; UNCLASSIFIED DRUG; WHITE PETROLATUM;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EPITHELIZATION; ERBIUM YAG LASER; HUMAN; LASER SURGERY; PRIORITY JOURNAL; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME; WOUND HEALING;

EID: 0031801228     PISSN: 10760512     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1524-4725.1998.tb04224.x     Document Type: Article

References (22)

1. Martin A. The use of antioxidants in healing. Dermatol Surg. 1996;22:156-60.
2. Levinson W. Toxic effect of x-irradiated medium on chick embryo cells. Exp Cell Res 1966;43:398-413.
3. DiGuiseppi J, Fridovich I. The toxicology of molecular oxygen: oxygen toxicity. CRC Crit Rev Toxicol 12:315-42.
4. Jamieson D. Oxygen toxicity and reactive oxygen metabolites in mammals. Free Radical Biol Med 1989;7:87-108.
5. Stocks J, Gutteridge MC, Sharp RJ, Dormandy TL. The inhibition of lipid autoxidation by human serum and its relation to serum proteins and alpha tocopherol. Clin Sci Mol Med 1974;47:223-33.
6. Alverez JG, Storey BT. Taurine, hypotaurine, epinephrine and albumin inhibit lipid peroxidation in rabbit spermatozoa and protect against loss of motility. Biol Reprod 1983;29:548-55.
7. O'Donnell-Tormey J, Nathan CF, Lanks K, DeBoar CJ, DeLaHarpe J. Secretion of pyruvate: An antioxidant defense of mammalian cells. J Exp Med 1987;165:500-14.
8. Mickle DAG, Li R, Weisel RD, Tumiati LC, Wu TW. Water-soluble antioxidant specificity against free radical injury using cultured human ventricular myocytes and fibroblasts and saphenous vein endothelial cells. J Mol Cell Cardiol 1990;22:1297-304.
9. Asman B, Wijkander P, Hjerpe A. Reduction of collagen degradation in experimental granulation tissue by vitamin E and selenium. J Clin Periodontol 1994;21:45-7.
10. Perchellet JP, Perchellet EM. Antioxidants and multistage carcinogenesis in mouse skin. Free Radical Biol Med 1989;7:377-408.
11. Halliwell B, Gutteridge JMC. Iron and free radical reactions: two aspects of antioxidant protection. Trends Biol Sci 1986;11:372-4.
12. Comporti M. Biology of disease: lipid peroxidation and cellular damage in toxic liver injury. Lab Invest 1985;3:599-623.
13. Phillips CL, Combs SB, Pinnell SR. Effects of ascorbic acid on proliferation and collagen synthesis in relation to the donor age of human dermal fibroblasts. J Invest Dermatol 1994;103:228-32.
14. Alster TS, West TB. Effect of topical Vitamin C on postoperative carbon dioxide laser resurfacing erythema. Dermatol Surg 1998; 24:331-4.
15. US Patent # 5,602,183. Dermatological wound healing composition and method for preparing and using.
16. US Patent # 5,614,561. Antihistamine wound healing composition and method for preparing and using.
17. US Patent # 5,633,285. Cytoprotective wound healing composition and method for preparing and using.
18. US Patent # 5,641,814. Antikeratolytic wound healing composition and method for preparing and using.
19. McDaniel DH, Ash K, Lord J, Newman J, Zukowski M. The Erbium:YAG laser: a review and preliminary report on resurfacing the face, neck, and hands. Aesth Surg Q 1997;17:157-64.
20. Bernstein LJ, Kauvar AN, Grossman MC, Geronemus RG. The short- and long-term side effects of carbon dioxide laser resurfacing. Dermatol Surg 1997;23:519-25.
21. Sheridan J, Kern E, Martin A, Booth A. Evaluation of antioxidant healing formulations in topical therapy of experimental cutaneous and genital herpes simplex virus infections. J Antiviral Research. 1997: in press.
22. Gokhale MS, Lin JR, Yager JD. A mixture of antioxidants and fatty acids improves the viability of cultured rat hepatocytes untreated or treated with doxyrubicin. Eur J Toxicol 1997: in press.